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Abstract
Background: Meandering main pancreatic duct (MMPD), which comprises loop type and reverse-Z type main pancreatic
duct (MPD), has long been discussed its relation to pancreatitis. However, no previous study has investigated its clinical
significance. We aimed to determine the non-biased prevalence and the effect of MMPD on idiopathic pancreatitis using
non-invasive magnetic resonance (MR) technique.
Methods and Findings: A cross-sectional study performed in a tertiary referral center. The study enrolled 504 subjects from
the community and 30 patients with idiopathic pancreatitis (7 acute, 13 chronic, and 10 recurrent acute). All subjects
underwent MR scanning and medical examination. MMPD was diagnosed when the MPD in the head of pancreas formed
two or more extrema in the horizontal direction on coronal images of MR cholangiopancreatography, making a loop or a
reverse-Z shaped hairpin curves and not accompanied by other pancreatic ductal anomaly. Statistical comparison was made
among groups on the rate of MMPD including loop and reverse-Z subtypes, MR findings, and clinical features. The rate of
MMPD was significantly higher for all idiopathic pancreatitis/idiopathic recurrent acute pancreatitis (RAP) (20%/40%;
P,0.001/0.0001; odds ratio (OR), 11.1/29.0) than in the community (2.2%) but was not higher for acute/chronic pancreatitis
(14%/8%; P=0.154/0.266). Multiple logistic regression analysis revealed MMPD to be a significant factor that induces
pancreatitis/RAP (P,0.0001/0.0001; OR, 4.01/26.2). Loop/reverse-Z subtypes were found more frequently in idiopathic RAP
subgroup (20%/20%; P=0.009/0.007; OR, 20.2/24.2) than in the community (1.2%/1.0%). The other clinical and radiographic
features were shown not associated with the onset of pancreatitis.
Conclusions: MMPD is a common anatomical variant and might be a relevant factor to the onset of idiopathic RAP.
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Introduction
Pancreatitis remains a serious disease and can be fatal in some
situations. Causes of pancreatitis include excessive alcohol
consumption, biliary stones, autoimmunity, trauma, heredity
factors including genetic mutations [1,2,3], and several morpho-
logical anomalies such as anomalous arrangement of the
pancreaticobiliary ductal system (AAPB) [4,5] or pancreas divisum
[5,6,7,8]. However, it is an important task to detect the cause of
idiopathic pancreatitis because as many as 20% of cases of
pancreatitis [8,9] and approximately 20–30% of cases of recurrent
acute pancreatitis (RAP) [10,11] remain idiopathic.
The main pancreatic duct (MPD) usually runs smoothly with
obtuse-angled curves from the tail and body of the pancreas
through the head of the pancreas to the major papilla; in other
words, it runs in the antero–posterior, cranio–caudal, and left–
right directions. However, we occasionally encounter patients
suffering idiopathic pancreatitis, especially idiopathic recurrent
acute pancreatitis (IRAP), who have a normal pancreaticobiliary
junction but have abnormal curvature in the ventral duct in the
head of the pancreas. In those cases, MPD forms a localized spiral
or hairpin curve with the appearance of a loop (loop type) or
hairpin (reverse-Z type) on coronal projection images of
endoscopic retrograde cholangiopancreatography (ERCP) or
magnetic resonance cholangiopancreatography (MRCP). Loop
type MPD was previously described in a series of AAPB [4] and in
a series of pancreas divisum [12], but reverse-Z type MPD was not
included in these studies. We grouped and defined these two
subtypes as ‘‘meandering main pancreatic duct’’ (MMPD) and we
hypothesised that MMPD may contribute in some way to the
onset of idiopathic pancreatitis.
PLoS ONE | www.plosone.org 1 May 2012 | Volume 7 | Issue 5 | e37652To the best of our knowledge, no previous study has investigated
the clinical significance of MMPD; however, this topic has long
been discussed among Japanese endoscopists as well as pancreas
divisum. In the present study, we aimed to determine the unbiased
prevalence rate of MMPD in a community population and the
effect of MMPD on idiopathic pancreatitis, especially on IRAP,
using a non-invasive magnetic resonance (MR) technique.
Materials and Methods
Based on the Declaration of Helsinki, Research Ethics
Committee of the University of Tokyo Hospital approved the
prospective and retrospective use of all the corresponding clinical,
biochemical, and radiographical data for the present study.
Subjects
The subjects were divided into two groups and three subgroups.
Those in group 1 (Community group) were consecutive subjects in
a community population who responded to leaflets and Internet
advertising. They participated in a whole-body medical check-up
program hosted by our hospital between 12 October 2006 and 31
March 2007, and were enrolled cross-sectionally. The program
included a blood test after overnight fasting, whole-body imaging
studies including abdominal MR scans and MRCP, evaluation of
smoking and drinking habits and medical history, an interview on
subjective symptoms, and a physical examination by a board-
certified physician. The blood test included white blood cells,
haemoglobin, platelets, amylase, C-reactive protein, glycated
haemoglobin, glucose, insulin, asparate aminotransferase, alanine
aminotransferase, gamma glutamyltransferase, alkaline phospha-
tase, total bilirubin, high-density lipoprotein, and low-density
lipoprotein. All data for each subject were acquired on the same
day. Written informed consent for comprehensive epidemiological
study was obtained from all subjects. Subjects who underwent the
full course of examinations listed above were included into the
study.
The subjects in group 2 (Idiopathic pancreatitis group) were a
group of patients with idiopathic pancreatitis, which comprised 3
subgroups: (1) idiopathic acute pancreatitis subgroup, (2) idiopath-
ic chronic pancreatitis subgroup, and (3) IRAP subgroup. They
were retrospectively extracted from consecutive patients suspected
to have any variation of pancreatitis, who visited our hospital
between 1 January 2003 and 31 December 2009 and underwent
abdominal MR scans including MRCP (patient group). To extract
all patients with definitive 3 types of idiopathic pancreatitis from
those patients, the entire medical record of each patient was
reviewed in detail and types of onset and the cause of pancreatitis
was assessed using the latest diagnostic criteria available at the
time of March 2010: (1) acute pancreatitis (JPN Guidelines for the
management of acute pancreatitis) [13], (2) chronic pancreatitis
(The revised Japanese clinical diagnostic criteria for chronic
pancreatitis) [14], and (3) RAP (defined as two or more well-
documented episodes of abdominal pain, typical of acute
pancreatitis, more than 2 months apart and at least one of the
following: (i) serum amylase or lipase elevation more than three
times the upper limit of normal, (ii) features of acute pancreatitis
on imaging [11,15]). Pancreatitis was diagnosed idiopathic by
board-certified gastroenterologists by exclusion of all established
causes of pancreatitis, by physical examination, biochemical, and
radiographical assessments (genetic and manometric assessments
were not done in all cases). Patients with RAP in Idiopathic
pancreatitis group belonged to IRAP subgroup. Patients with
incomplete evaluations, insufficient MR image quality, post
pancreatoduodenectomy state, and neoplasm in the head of
pancreas were excluded. Severity of acute and recurrent acute
pancreatitis was determined according to the severity scoring
system of acute pancreatitis of the Japanese Ministry of Health,
Labour, and Welfare (the JPN score 2008) (grade 3–9 was
considered severe) [16], contrast-enhanced computed tomography
grade (grade 2–3 was considered severe) [16], and non-enhanced
computed tomography grade (grade 4–5 was considered severe)
[17,18]), and also to Ranson score (score 3–11 was considered
severe) [19] and modified Glasgow score (score 3–8 was
considered severe) [20]. Stage of chronic pancreatitis (A, early;
B, intermediate; C, end stage) was determined according to a
recently proposed criteria [21,22]. The region of pancreatitis
(undetectable; head; body; tail; two or more of these regions) was
also recorded [16]. Comprehensive written informed consent for
retrospective use of clinical data was obtained from all patients
prior to enrolment.
MR imaging technique
For Community group, MR studies were performed on 3 T
scanners (GE Medical Systems, Waukesha, WI). Heavily T2-
weighted MRCP images were acquired in the coronal plane by
breath-hold two-dimensional half-Fourier fast spin echo (repetition
time (TR)/echo time (TE)=‘/600 ms; slice thickness
(ST)=40 mm) with four coronal and oblique-coronal projection
images. For complementary interpretation, transaxial fast spin
echo T2-weighted images (TR/TE=‘/80 ms; ST=3 mm with
no gap) and fat-suppressed T1-weighted images with three-
dimensional gradient echo technique (TR/TE=3.5/1.5 ms; flip
angle=15u; ST=3 mm with 1.5 mm overlap) were also acquired.
No premedication was administered.
For patient group, MR studies were performed on a 3 T scanner
(GE Medical Systems) or on a 1.5 T scanner (GE Medical Systems;
Siemens AG, Erlangen, Germany; and Toshiba Medical Systems,
Tochigi, Japan). Heavily T2-weighted MRCP images were
acquired by breath-hold two-dimensional half-Fourier fast spin
echo (TR/TE=2400–‘/600–1100 ms; ST=30–50 mm) and
respiratory-gated three-dimensional half-Fourier fast spin echo
(TR/TE=1300–‘/500–900 ms; ST=1.2–2.0 mm with no gap),
and coronal and oblique-coronal projection images were recon-
structed. For complementary interpretation, transaxial and coro-
nal fast spin echo T2-weighted images (TR/TE=1300–‘/80–
150 ms; ST=5 mm with no gap) and fat-suppressed T1-weighted
images with three-dimensional gradient echo technique (TR/
TE=3–840/1.5–140 ms; flip angle=15u; ST=1.5 mm with no
gap) were also acquired. Manganese chloride solution (Bothdel
Oral Solution 10; Kyowa Hakko Kirin, Tokyo, Japan) was
administered as negative oral contrast agent prior to MR
scanning.
Image interpretation
All MR images were interpreted independently on picture
archiving and communication system workstations (Centricity; GE
Medical Systems) by two board-certified diagnostic radiologists
with experience in pancreaticobiliary imaging, who were blinded
to clinical information. Images determined not to visualize
pancreatic ductal anatomy in the head of pancreas clearly by
either of the two radiologists were excluded from analyses. Also
excluded were images with post pancreatoduodenectomy state or
those with neoplasm in the head of the pancreas.
The MR data sets were then evaluated for pancreatic ductal
anatomy. On (oblique-)coronal planes of MRCP studies, the shape
of MPD in the head of pancreas was compared to a mathematical
curve assuming a line vertical to the body axis as a y-axis and the
body axis as an x-axis (Figure 1). Under this condition, normal
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seemingly has one inflexion point and has no extremum. MMPD
was defined on (oblique-)coronal MRCP plane when (1) located in
the head of pancreas; (2) the curve of MPD has two or more
extrema in the direction that are vertical to the body axis, forming
a curve or angle to make a localized loop (loop type) or reverse-Z
shaped hairpins (reverse-Z type); (3) it is not accompanied by
AAPB or pancreas divisum (complete or incomplete).
The radiologists were asked to determine if MMPD was present
or not and the morphological patterns of MMPD (loop or reverse-
Z type) on MRCP images according to its definition and a schema
of MMPD (Figure 1) revised from a classification system
established previously [12]. Any radiographic findings related to
the pancreaticobiliary system were also recorded, if present (e.g.,
other pancreatic ductal fusion variants, pancreatic cystic lesions,
pancreatic ductal/ductile dilatation or irregularity, pancreatic
parenchymal atrophy, gallstones, cystic polyps, adenomyomatosis,
biliary morphological defects, juxtapapillary duodenal diverticu-
lum). Discrepancies between the two radiologists were settled by
the third expert diagnostic radiologist.
Statistical analysis
Comparison between groups was performed by Student’s t-test
for numerical data and Fisher’s exact test for nominal data
(univariate analyses). The level of statistical significance was set at
0.05. Family-wise error was corrected by Bonferroni’s method. In
addition, multiple logistic regression analysis was employed to
explore relevant factors for pancreatitis and RAP. To compare the
effect of MMPD and pancreas divisum on pancreatitis and RAP,
additional multiple logistic regression analysis was made with data
including preliminarily excluded patients with pancreas divisum
(the same subject group as our previous study [8]). To avoid
overestimating the number of predictive values, we selected
variables with P,0.05 prior to family-wise error correction at
univariate analyses. All statistical computing was performed using
the free software R Ver. 2.9 (The R Foundation for Statistical
Computing, Vienna, Austria, http://cran.r-project.org/).
Results
Subjects
In Community group, 540 subjects fulfilled the whole study,
with the following exclusions: incomplete MR scans (n=1), post
pancreatoduodenectomy (n=1), intraductal pancreatic mucinous
neoplasm in the head of the pancreas (n=3), and insufficient
image quality (most commonly gastrointestinal signal hindering
visualisation of the pancreatic ducts) (n=31). The final total of 504
subjects included 205 females (age, 35–84 years; mean, 57.3 years)
and 299 males (age, 38–83 years; mean, 56.0 years). One subject
was Korean; all others were Japanese. No subject complained of a
pancreatic pain.
In patient group, we identified 3,225 MRCP studies from a total
of 70,112 MR studies. After excluding patients without pancre-
atitis, cases of tumor-induced pancreatitis, patients with incom-
plete evaluation, and overlaps, 237 patients with non-tumor-
induced pancreatitis were extracted for analysis (Table 1). After 16
patients with pancreas divisum and one with insufficient image
quality (gastrointestinal signal hindering pancreatic ducts) were
excluded, we found a final total of 30 cases of definitive idiopathic
pancreatitis including 15 females (age, 35–77 years; mean, 54.7
years) and 15 males (age, 24–82 years; mean, 60.4 years), 10 of
which were cases of IRAP including 8 females (age, 40–77 years;
mean, 54.1 years) and 2 males (age, 63–64 years; mean, 63.5 years)
(Table 2, 3, and 4). They were all Japanese.
Findings and statistical results
MPD in the head of pancreas was clearly visualized in 94.3%
(509/540) of Community group and 96.8% (30/31) of Idiopathic
pancreatitis group with no significant difference between the
groups (Fisher’s exact test, P=0.90).
In both groups, all MMPD were classified into two categories
without ambiguity (no discrepancy was found between the two
radiologists): loop type and reverse-Z type (Figure 2). No part of
the MPD was shown to run in a postero–anterior direction in any
subject.
In Community group, 2.2% (11/504) of subjects had MMPD,
including 6 cases of loop type and five of reverse-Z type (Table 5).
Pancreas divisum was observed in other 2.6% (13/504) of patients
[8] and the others were normal type. A history of hyperlipidemia
was more common in subjects with MMPD than without (Table 2).
Otherwise, no significant differences were detected in terms of age,
gender, clinical history (Table 2), hematologic and biochemical
values, or radiographic findings (the only radiographic finding in
MMPD subject was 1 adenomyomatosis accompanied by loop
type).
In Idiopathic pancreatitis group, 20.0% (6/30) patients had
MMPD, which included two cases of loop type and four of reverse-
Z type (Table 5). In IRAP subgroup, 40.0% (4/10) patients had
MMPD, which included 2 cases of loop type and 2 of reverse-Z
type (Table 5). No MMPD was accompanied by other morpho-
logical abnormalities. The others were all normal type. No
significant differences in clinical features were detected between
subjects with and without MMPD in Idiopathic pancreatitis group
(Table 3, P1) and in IRAP subgroup (Table 4, P1).
In comparing Community group and Idiopathic pancreatitis
group, no difference in clinical features was detected except for a
higher frequency of pancreatitis in Idiopathic pancreatitis group
than in Community group (Table 3, P2). However, a higher
frequency of pancreatitis, a lower score of Brinkman index, and a
Figure 1. Schematic images of meandering main pancreatic
duct (MMPD). The thick line indicates the common bile duct, and the
thin line indicates the main pancreatic duct. MMPD was classified into
subtypes based on its morphology in the head of pancreas on magnetic
resonance cholangiopancreatography: normal type (A), examples of
loop type (B1–2), and examples of reverse-Z type (C1–3). Assuming the
body-axis as x-axis and horizontal direction as y-axis, MPD curves in
loop and reverse-Z types have two extrema in horizontal direction
respectively (arrows), while normal type has none. Dorsal pancreatic
duct could be observed or not.
doi:10.1371/journal.pone.0037652.g001
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subgroup than in Community group (Table 4, P2). The rate of
MMPD and that of loop and reverse-Z types, respectively, were
significantly higher in IRAP subgroup than in Community group,
with the accompanying odds ratios (ORs) being remarkably high,
but these findings did not apply to cases of idiopathic acute/
chronic pancreatitis (Table 5).
Multiple logistic regression analysis using MMPD and hyper-
lipidemia as independent covariates, according to the results of
univariate analyses, revealed a significant positive association of
Table 1. Distribution of the causes of non-tumor-induced pancreatitis in patient group.
Type of pancreatitis
Cause of pancreatitis All Acute Chronic Recurrent acute
(n=237) (n=42) (n=166) (n=29)
Alcohol 90 [38] 8 [19] 75 [45] 7 [24]
Autoimmunity
a 52 [22] 2 [5] 49 [30] 1 [3]
Idiopathic 31 [13] 7 [17] 14 [8] 10 [34]
Gallstones 26 [11] 16 [38] 8 [5] 2 [7]
Pancreas divisum
b 16 [7] 1 [2] 10 [6] 5 [17]
Crohn’s disease 3 [1] 1 [2] 2 [1] 0 [0]
Choledochal cyst 3 [1] 3 [7] 0 [0] 0 [0]
Ulcerative colitis treated with salazosulfapyridine 2 [1] 0 [0] 1 [1] 1 [3]
Pancreatic calculus due to IPMN 2 [1] 0 [0] 1 [1] 1 [3]
Hyperlipidemia 2 [1] 1 [2] 0 [0] 1 [3]
Heredity 2 [1] 0 [0] 2 [1] 0 [0]
Alcohol and gallstones combined 2 [1] 0 [0] 2 [1] 0 [0]
Sphincter of Oddi dysfunction 1 [0] 0 [0] 0 [0] 1 [3]
Pancreaticobiliary maljunction 1 [0] 0 [0] 1 [1] 0 [0]
Trauma 1 [0] 1 [2] 0 [0] 0 [0]
Hypothermia 1 [0] 1 [2] 0 [0] 0 [0]
Hypercalcemia 1 [0] 0 [0] 1 [1] 0 [0]
Cholesterol embolism 1 [0] 1 [2] 0 [0] 0 [0]
a,Diagnosed according to the Asian Diagnostic Criteria of Autoimmune Pancreatitis revised in 2008 [39];
b,Diagnosed by exclusion [8]; IPMN, intraductal papillary mucinous neoplasm.
Numbers in square brackets represent percentages.
doi:10.1371/journal.pone.0037652.t001
Table 2. Clinical features of subjects in Community group with and without meandering main pancreatic duct (MMPD).
Community group
All MMPD Non-MMPD P
(n=504) (n=11) (n=493)
Age (years) (mean [SD]) 56.5 [10.8] 51.4 [11.7] 56.6 [10.1] 0.17
b
Female (n [%]) 205 [40] 4 [36] 201 [40] 1
c
Brinkman index (cigarettes/day6year) (mean [SD]) 314 [459] 171 [300] 317 [461] 0.14
b
Alcohol intake (kg/year) (mean [SD]) 10.6 [17.1] 17.6 [30.7] 10.5 [16.7] 0.31
b
Clinical history
Pancreatitis (n [%]) 1 [0] 0 [0] 1 [0] 1
c
Diabetes mellitus (n [%]) 30 [6] 1 [9] 29 [6] 0.49
c
Hypertension (n [%]) 79 [16] 0 [0] 79 [16] 0.23
c
Hyperlipidemia (n [%]) 56 [11] 6 [55] 50 [10] 0.004
a,c
Any malignant neoplasm (n [%]) 25 [5] 0 [0] 25 [5] 1
c
a,Significant after family-wise correction;
b,Student’s t-test;
c,Fisher’s exact test; P, P-value for the test between Community group subjects with and without MMPD; SD, standard deviation.
doi:10.1371/journal.pone.0037652.t002
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confidence interval (CI), 1.92–6.11]) and RAP (P,0.0001; OR,
26.2 [95% CI, 22.2–30.2]). Positive association of loop/reverse-Z
type to the onset of RAP was also detected (P=0.0006/0.0009;
OR, 21.6/18.5 [95% CI, 15.9–27.3/12.9–24.0]).
Additional multiple logistic regression analysis including pre-
liminarily excluded 16 patients with pancreas divisum revealed a
relatively weak association of MMPD to the onset of pancreatitis
(P,0.0001; OR, 10.5 [95% CI, 3.57–30.6]) compared to that of
pancreas divisum (P,0.0001; OR, 23.6 [95% CI, 10.2–54.4]) and
a relatively strong association of MMPD to the onset of RAP
(P,0.0001; OR, 21.8 [95% CI, 5.68–84.0]) compared to that of
pancreas divisum (P,0.0001; OR, 14.8 [95% CI, 4.37–50.0])
Pancreatitis in patients with MMPD and idiopathic acute
pancreatitis or IRAP was possibly less severe and more undetect-
able or localized in the head of pancreas than pancreatitis in
patients without MMPD (Tables 6 and 7); however no significant
statistical analysis was available due to insufficient number of data.
In patients with idiopathic chronic pancreatitis, the only patient
with MMPD had early stage chronic pancreatitis in the head of
pancreas, while those without MMPD comprised 7 early, 4
intermediate, and 1 end stage.
Table 3. Clinical features of subjects in Idiopathic pancreatitis group with and without meandering main pancreatic duct (MMPD).
Idiopathic pancreatitis group Inter-group
All MMPD Non-MMPD P1 P2
(n=30) (n=6) (n=24)
Age (years) (mean [SD]) 57.6 [15.6] 60.7 [9.7] 56.8 [15.6] 0.56
b 0.73
b
Female (n [%]) 15 [50] 4 [67] 11 [46] 0.66
c 0.34
c
Brinkman index (cigarettes/day6year)
(mean [SD])
255 [621] 0 [0] 319 [682] 0.031
b 0.61
b
Alcohol intake (kg/year) (mean [SD]) 5.0 [12.5] 0.2 [14.8] 6.2 [16.4] 0.086
b 0.059
b
Clinical history
Pancreatitis (n [%]) 30 [100] 6 [100] 24 [100] 1
c ,0.0001
a,c
Diabetes mellitus (n [%]) 3 [10] 0 [0] 3 [13] 1
c 0.42
c
Hypertension (n [%]) 5 [17] 0 [0] 5 [21] 0.55
c 1
c
Hyperlipidemia (n [%]) 3 [10] 1 [17] 2 [8] 0.50
c 1
c
Any malignant neoplasm (n [%]) 2 [7] 1 [17] 1 [4] 0.37
c 0.66
c
a,Significant after family-wise correction;
b,Student’s t-test;
c,Fisher’s exact test; P1, P-value for the test between idiopathic pancreatitis patients with and without MMPD; P2, P-value for intergroup test between Community group
(Table 2) and Idiopathic pancreatitis group; SD, standard deviation.
doi:10.1371/journal.pone.0037652.t003
Table 4. Clinical features of subjects in Idiopathic recurrent acute pancreatitis (IRAP) subgroup with and without meandering main
pancreatic duct (MMPD).
IRAP subgroup Inter-group
All MMPD Non-MMPD P1 P2
(n=10) (n=4) (n=6)
Age (years) (mean [SD]) 56 [12.0] 54 [9.9] 57.3 [13.9] 0.67
b 0.89
b
Female (n [%]) 8 [80] 4 [100] 4 [67] 0.47
c 0.02
c
Brinkman index (cigarettes/day6year) (mean [SD]) 0 [0] 0 [0] 0 [0] 1
b ,0.0001
a,b
Alcohol intake (kg/year) (mean [SD]) 0.2 [0.2] 0.3 [0.3] 0.1 [0.2] 0.36
b ,0.0001
a,b
Clinical history
Pancreatitis (n [%]) 10 [100] 4 [100] 6 [100] 1
c ,0.0001
a,c
Diabetes mellitus (n [%]) 0 [0] 0 [0] 0 [0] 1
c 1
c
Hypertension (n [%]) 1 [10] 0 [0] 1 [17] 1
c 1
c
Hyperlipidemia (n [%]) 0 [0] 0 [0] 0 [0] 1
c 0.61
c
Any malignant neoplasm (n [%]) 1 [10] 1 [25] 0 [0] 0.40
c 0.41
c
a,Significant after family-wise correction;
b,Student’s t-test;
c,Fisher’s exact test; P1, P-value for the test between IRAP subjects with and without MMPD; P2, P-value for intergroup test between Community group (Table 2) and
IRAP subgroup; SD, standard deviation.
doi:10.1371/journal.pone.0037652.t004
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This is the first study to focus on the clinical significance of
MMPD. We defined MMPD as the MPD forming a loop or a
reverse-Z curve in the head of the pancreas in patients with
normal pancreaticobiliary junction.We determined the prevalence
of MMPD and its subtypes in a community population and in
patients with idiopathic pancreatitis using MRCP, and found that
the existence of MMPD and its subtypes were significantly
associated with the onset of IRAP.
MRCP is a non-invasive diagnostic MR technique that depicts
the pancreatic ducts free from radiation exposure, post-procedural
pancreatitis, and injection of contrast medium, and has been
shown to be highly sensitive and specific (90%–100% for 1.5 T
systems) for depicting ventral and dorsal pancreatic ducts
[23,24,25,26]. An additional advantage of MRCP is its ability to
Figure 2. Anatomical variations of meandering main pancreatic
duct as seen on magnetic resonance images. (A) Normal type on a
magnetic resonance cholangiopancreatography (MRCP) image, (B) loop
type on an MRCP image, (C and D) reverse-Z type on MRCP images. The
white arrow on subfigures (B, C, D) indicates an abnormally curved
section of the main pancreatic duct in the head of pancreas.
doi:10.1371/journal.pone.0037652.g002
Table 5. Frequency of meandering main pancreatic duct (MMPD) and its contribution to idiopathic pancreatitis arranged by
anatomical subtypes of MMPD and onset types of idiopathic pancreatitis.
All MMPD
b Non-MMPD P
c OR
d
Community 11 [2] 493
All idiopathic 6 [20] 24 ,0.001
a 11.1 [3.1–36.2]
Acute 1 [14] 6 0.154
Chronic 1 [8] 12 0.266
Recurrent acute 4 [40] 6 ,0.0001
a 29.0 [5.3–144.3]
Loop type
b Else P
c OR
d
Community 6 [1] 498
All idiopathic 2 [7] 28 0.069
Acute 0 [0] 7 1
Chronic 0 [0] 13 1
Recurrent acute 2 [20] 8 0.009
a 20.2 [1.7–139.4]
Reverse-Z type
b Else P
c OR
d
Community 5 [1] 499
All idiopathic 4 [13] 26 ,0.001
a 15.1 [2.8–75.0]
Acute 1 [14] 6 0.080
Chronic 1 [8] 12 0.142
Recurrent acute 2 [20] 8 0.007
a 24.2 [2.0–179.2]
a, significant;
b,numbers in square brackets represent percentages;
c,Fisher’s exact test;
d,numbers in square brackets represent the 95% confidence interval; OR, odds ratio.
doi:10.1371/journal.pone.0037652.t005
Table 6. Rate of severe pancreatitis in patients with
idiopathic acute and recurrent acute pancreatitis.
Severity index (considered severe) MMPD Non-MMPD
CECT score (.=2) [16] 1/4 [25%] 3/7 [43%]
NECT score (.=4) [17,18] 1/4 [25%] 3/9 [33%]
JPN score 2008 (.=3) [16] 0/5 [0%] 0/11 [0%]
Ranson score (.=3) [19] 0/5 [0%] 1/11 [9%]
Modified Glasgow score (.=3) [20] 0/5 [0%] 1/11 [9%]
CECT, contrast enhanced computed tomography; JPN, Japan; MMPD,
meandering main pancreatic duct; NECT, non-enhanced computed
tomography.
doi:10.1371/journal.pone.0037652.t006
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tion and to depict pseudocysts and mucosal fluid [25]. The
disadvantage of MRCP is its limitation in evaluating ampullary
lesions [25]. Although secretin-enhanced MRCP is reported to
improve pancreatic ductal visualization [27], abnormal responses
of MPD to secretin stimulation were previously detected in 12%
(8/67) of patients with idiopathic acute pancreatitis including
IRAP [27,28] (anyway, secretin is unavailable in Japan); thus, non-
contrasted MRCP alone has been reasonably applicable to the
healthy population without clinical indications and to patients in a
severe condition such as RAP for the purpose of visualizing
pancreatic ductal anatomy. For these reasons, MRCP is routinely
performed on patients with pancreatitis of unknown etiology (at
the first complete examination or during the follow-up period) to
assess the state of the pancreatic ducts and to check for
pancreaticobiliary disease in our hospital.
The distribution of the causes of non-tumor-induced pancrea-
titis including RAP, as obtained in the present study, grossly
coincided with that described previously [5,9,10,11], although we
observed a slightly lower rate of biliary diseases and higher rate of
autoimmune pancreatitis. This could be explained as a result of
our hospital being a tertiary referral center and also because
autoimmune pancreatitis is a recently established disease and its
definition is changing and expanding.
In the present study, MMPD was present in 2.2% of the
Community group and in 20.0%/40.0% of patients with
idiopathic pancreatitis/IRAP. A previous endoscopy-based study
on pancreatic ductal anatomy found loop type MPD in 6.5% (38/
585) of a patient group suspected to have pancreaticobiliary
disease [12] and 5.4% (2/37) of patients with AAPB [4]. In our
other study focusing on alcoholic pancreatitis, only 5.6% (5/90) of
patients with alcoholic pancreatitis had MMPD, diagnosed by the
same radiologists carefully using the same criteria as in the present
study (Gonoi et al. Unpublished). Both these results and those of
the present study appear to agree with the hypothesis that MMPD
is associated with idiopathic pancreatitis. The rate of MMPD in
the Community group was occasionally similar to that of pancreas
divisum [8,29], which is the most common anatomical variant of
the pancreas and is found four times as frequently as in European
(5.8%) and American (6.0%) population than in Asian population
(1.5%) (systematic review) [29]. MMPD might also be found more
frequently in European and American population.
Statistical tests comparing Community group to Idiopathic
pancreatitis group and IRAP subgroup revealed that MMPD and
its subtypes were closely associated with idiopathic pancreatitis and
IRAP, supporting the hypothesis of MMPD being a predisposing
factor. Lower consumption of alcohol and cigarette in the IRAP
subgroup could be because they were told to abstain by their
physicians.
In the Community group, history of hyperlipidemia was more
common in subjects with MMPD than in those without, while no
coincident results were detected in hematologic values probably
because they were medicated. No association between hyperlip-
idemia and MMPD or other pancreatic morphological variations
has been reported. However, hyperlipidemia has been reported to
cause pancreatitis in pregnancy [30].
Although the present results revealed a strong association
between MMPD and pancreatitis, no subject with MMPD in
Community group had a history of pancreatitis, radiographic
findings, or laboratory data indicative of pancreatitis. We speculate
that MMPD may be a predisposing factor for pancreatitis but that
small numbers of individuals with MMPD become symptomatic
with pancreatitis. This phenomenon is similar to that associated
with other pancreatic ductal anomalies; for example, only 5%–
10% of patients with pancreas divisum become symptomatic with
pancreatitis [28,31].
The etiology of MMPD is unknown. MMPD is located in the
head of the pancreas, where several fusion variations of the ventral
and dorsal ducts exist; e.g., AAPB [4,5], pancreas divisum
[5,6,7,8,23,24,25,31,32], ansa pancreatica [4,33], retroportal
MPD [34], and other various non-classifiable fusion variants
[4,12,35,36,37]. Of these variants, AAPB [5], pancreas divisum
[8,38], and ansa pancreatica [33], however controversial, have
been reported to be associated with pancreatitis and the present
results revealed a similar contribution of MMPD and pancreas
divisum to the onset of pancreatitis and RAP. Thus, we speculate
MMPD to be an analogue of developmental variants that result
from abnormal fusion of the ventral and dorsal anlagen of the
pancreas in the fetal stage, rather than a pancreatic ductal
irregularity caused by pancreatitis.
The mechanism by which MMPD is associated with RAP is not
yet elucidated. As we observed no MPD and dorsal pancreatic
ductal dilatation or pancreatic parenchymal atrophy associated
with MMPD, mechanical obstruction theory as proposed in
pancreas divisum seems less conceivable [25,28,31]; however, in
the present study, the only specified region of pancreatitis in cases
with MMPD was the head of pancreas, and after the present study
series, we have experienced a single case of reverse-Z type
accompanied by Wirsungocele, which may support the mechan-
ical obstruction theory. Otherwise, some genetic etiologies could
be accompanied by the presence of MMPD; like as cystic fibrosis
transmembrane conductance regulator gene (CFTR) being found
frequently in patients with pancreas divisum and RAP [1,38].
Alternatively, some genetic mutations, such as CTFR [3] or serine
protease inhibitor Kazal type 1 [1,2] themselves might be the
causative factor for RAP in the presence of MMPD. Further
investigation is needed.
The major limitation in the present study is that the definition of
MMPD has some arbitrariness. Although it might be less practical,
more strict three-dimensional and mathematical analysis could be
performed in the future study. Minor limitations are as follows.
First, the subjects in Community group were not randomly chosen
from the community and might be more interested in health.
Second, the MR scans in Idiopathic pancreatitis group were
acquired by non-identical, but quite similar, settings. Third, in
some cases, MRCP might have failed to visualize a thin looped
type MPD and misclassified it into normal type due to limited
spatial resolution. Fourth, the present study was a cross-sectional
study and we did not show experimental or prospective evidence
that MMPD causes pancreatitis as well as pathological assessment.
In a strict sense, a long-term follow-up study is required that
includes a large number of individuals with MMPD, from a young
age. Finally, as our study group included small numbers of IRAP
Table 7. Involved regions in idiopathic acute and recurrent
acute pancreatitis.
Region MMPD Non-MMPD
Undetectable 2/4 [50%] 0/10 [0%]
Head 2/4 [50%] 4/10 [40%]
Body 0/4 [0%] 1/10 [10%]
Tail 0/4 [0%] 1/10 [10%]
Two or more regions 0/4 [0%] 4/10 [40%]
MMPD, meandering main pancreatic duct.
doi:10.1371/journal.pone.0037652.t007
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anatomy in a larger group of IRAP, which would require a
multicenter collaborative study.
In conclusion, this is the first study to focus on the clinical
significance of MMPD. We revealed that MMPD is a relatively
common variation of the pancreatic ductal anatomy and that it is
found highly frequently in patients with IRAP. We conclude that
MMPD might be considered a relevant factor to the onset of
IRAP.
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